U.S. pharmaceutical company Johnson & Johnson said Monday it has filed for Japanese health ministry approval of its novel coronavirus vaccine through its local unit.If approved, Johnson & Johnson said its vaccine could be delivered to Japan in early 2022, becoming the fourth vaccine in the fight against COVID-19 in the country, which is lagging behind other nations in its vaccine rollout.According to the unit, Janssen Pharmaceutical K.K., its Phase 1 study results from 250 healthy people between the ages of 20 and 55 and those aged 65 or older in Japan showed that the one-shot vaccine did n…READ FULL ARTICLE
